Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome ...
A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effect ...
Lennox-Gastaut Syndrome
Drug: Rufinamide;Drug: Any other approved Antiepileptic Drug
Eisai Inc.
NULL
Completed
1 Year
3 Years
All
37
Phase 3
United States;Canada;France;Greece;Italy;Poland;South Africa;India